SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-005720
Filing Date
2016-06-01
Accepted
2016-06-01 08:22:36
Documents
3
Period of Report
2016-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K s103378_8k.htm 8-K 36888
2 EXHIBIT 99.1 s103378_99-1.htm EX-99.1 18935
3 GRAPHIC logo.jpg GRAPHIC 4911
  Complete submission text file 0001615774-16-005720.txt   64026
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 161687965
SIC: 2834 Pharmaceutical Preparations